Fibrometabolism—An emerging therapeutic frontier in pulmonary fibrosis
Sign Up to like & getrecommendations! Published in 2021 at "Science Signaling"
DOI: 10.1126/scisignal.aay1027
Abstract: Metabolic reprogramming of myofibroblasts promotes fibrosis and could be targeted to treat fibrotic diseases. Fibrosis is the final pathological outcome and major cause of morbidity and mortality in many common and chronic inflammatory, immune-mediated, and… read more here.
Keywords: fibrometabolism emerging; frontier pulmonary; therapeutic frontier; emerging therapeutic ... See more keywords